-- Juno Therapeutics files for IPO
-- By Avik Das in Bangalore
-- Mon Nov 17, 2014 06:32AM EST
-- None



Nov 17 (Reuters) - Juno Therapeutics Inc filed with U.S. regulators for an initial public offering of its common stock.

Morgan Stanley, J.P. Morgan and Goldman Sachs & Co were underwriting the IPO, the biopharmaceutical company told the U.S Securities and Exchange Commission in a preliminary prospectus on Monday. The filing included a nominal fundraising target of about $150 million. (http://1.usa.gov/1zvEfJ1)